204 related articles for article (PubMed ID: 14766970)
1. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.
Qiu SR; Wierzbicki A; Orme CA; Cody AM; Hoyer JR; Nancollas GH; Zepeda S; De Yoreo JJ
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1811-5. PubMed ID: 14766970
[TBL] [Abstract][Full Text] [Related]
2. Molecular modulation of calcium oxalate crystallization.
De Yoreo JJ; Qiu SR; Hoyer JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
[TBL] [Abstract][Full Text] [Related]
3. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
[TBL] [Abstract][Full Text] [Related]
4. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.
Qiu SR; Wierzbicki A; Salter EA; Zepeda S; Orme CA; Hoyer JR; Nancollas GH; Cody AM; De Yoreo JJ
J Am Chem Soc; 2005 Jun; 127(25):9036-44. PubMed ID: 15969581
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Pathways for the Molecular Step Growth of Calcium Oxalate Monohydrate Crystal Revealed by In Situ Liquid-Phase Atomic Force Microscopy.
Cho KR; Lee JH; Seo HS; Ji Y; Park JH; Lee SE; Kim HW; Wu KJJ; Kulshreshtha P
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37873-37882. PubMed ID: 34327985
[TBL] [Abstract][Full Text] [Related]
6. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
Langdon A; Grohe B
Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
[TBL] [Abstract][Full Text] [Related]
8. Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.
Sheng X; Jung T; Wesson JA; Ward MD
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):267-72. PubMed ID: 15625112
[TBL] [Abstract][Full Text] [Related]
9. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
10. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
[TBL] [Abstract][Full Text] [Related]
11. Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.
Wang L; Qiu SR; Zachowicz W; Guan X; Deyoreo JJ; Nancollas GH; Hoyer JR
Langmuir; 2006 Aug; 22(17):7279-85. PubMed ID: 16893227
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.
Gleberzon JS; Liao Y; Mittler S; Goldberg HA; Grohe B
Urolithiasis; 2019 Oct; 47(5):425-440. PubMed ID: 30569197
[TBL] [Abstract][Full Text] [Related]
13. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
Sheng X; Ward MD; Wesson JA
J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
[TBL] [Abstract][Full Text] [Related]
14. Exploring calcium oxalate crystallization: a constant composition approach.
Kolbach-Mandel AM; Kleinman JG; Wesson JA
Urolithiasis; 2015 Oct; 43(5):397-409. PubMed ID: 26016572
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
Hoyer JR; Asplin JR; Otvos L
Kidney Int; 2001 Jul; 60(1):77-82. PubMed ID: 11422738
[TBL] [Abstract][Full Text] [Related]
16. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.
Taller A; Grohe B; Rogers KA; Goldberg HA; Hunter GK
Biophys J; 2007 Sep; 93(5):1768-77. PubMed ID: 17496021
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
Asokan D; Kalaiselvi P; Varalakshmi P
Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
[TBL] [Abstract][Full Text] [Related]
18. Reversible inhibition of calcium oxalate monohydrate growth by an osteopontin phosphopeptide.
Nene SS; Hunter GK; Goldberg HA; Hutter JL
Langmuir; 2013 May; 29(21):6287-95. PubMed ID: 23611580
[TBL] [Abstract][Full Text] [Related]
19. Scanning electron microscopy and molecular modeling of inhibition of calcium oxalate monohydrate crystal growth by citrate and phosphocitrate.
Wierzbicki A; Sikes CS; Sallis JD; Madura JD; Stevens ED; Martin KL
Calcif Tissue Int; 1995 Apr; 56(4):297-304. PubMed ID: 7767841
[TBL] [Abstract][Full Text] [Related]
20. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
